Last $0.05 USD
Change Today -0.0005 / -1.10%
Volume 1.1K
PARS On Other Exchanges
Symbol
Exchange
OTC US
As of 5:19 PM 01/26/15 All times are local (Market data is delayed by at least 15 minutes).

pharmos corp (PARS) Snapshot

Open
$0.05
Previous Close
$0.05
Day High
$0.05
Day Low
$0.05
52 Week High
11/6/14 - $0.31
52 Week Low
08/25/14 - $0.03
Market Cap
2.7M
Average Volume 10 Days
12.7K
EPS TTM
$-0.04
Shares Outstanding
60.2M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PHARMOS CORP (PARS)

Related News

No related news articles were found.

pharmos corp (PARS) Related Businessweek News

No Related Businessweek News Found

pharmos corp (PARS) Details

Pharmos Corporation, a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat a range of metabolic and nervous system disorders. The company focuses on the disorders of the brain-gut axis, pain/inflammation, and autoimmune, as well as gout disorders. Its lead compounds under clinically development include Levotofisopam, a non-sedating agent for the treatment of Gout; and Dextofisopam, a non-serotonergic agent which has completed Phase IIa and Phase IIb clinical trials for the treatment of irritable bowel syndrome. The company was founded in 1990 and is headquartered in Iselin, New Jersey.

2 Employees
Last Reported Date: 02/17/12
Founded in 1990

pharmos corp (PARS) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PARS:US $0.05 USD -0.0005

PARS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PARS.
View Industry Companies
 

Industry Analysis

PARS

Industry Average

Valuation PARS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PHARMOS CORP, please visit www.pharmoscorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.